Intraperitoneal bispecific antibody (HEA125xOKT3) therapy inhibits malignant ascites production in advanced ovarian carcinoma
2002 ◽
Vol 101
(2)
◽
pp. 183-189
◽
Keyword(s):
2006 ◽
Vol 2006
◽
pp. 470-472
Keyword(s):
1988 ◽
Vol 30
(3)
◽
pp. 347-358
◽
Keyword(s):
Keyword(s):
1982 ◽
Vol 14
(2)
◽
pp. 262-270
◽
1990 ◽
Vol 116
(3)
◽
pp. 283-287
◽
Keyword(s):